References
- Wolfe F, Kleinheksel S M, Spitz P W, Lubeck D P, Fries J F, Young D Y, et al. A multicentre study of hospitalisation in rheumatoid arthritis. Frequency, medical‐surgical admissions and charges. Arthritis Rheum 1986; 29: 614–9
- Hazleman B L. Incidence of gastropathy in destructive arthropathies. Scand J Rheumatol 1989; 78: 1–4, Suppl
- Butt J H. Clinical spectrum of the upper gastrointestinal effects of nonsteroidal anti‐inflammatory drugs. Natural history, symptomatology and significance. Am J Med 1988; 84(Suppl 2A)5–14
- Larkai E N, Smith J L, Lidsky M D, Sessoms S L, Graham D Y. Dyspepsia in NSAID users: the size of the problem. J Clin Gastroenterol 1989; 11: 158–62
- McCarthy D M. Non‐steroidal anti‐inflammatory drug‐induced ulcers: management by traditional therapies. Gastroenterology 1989; 96: 662–74
- Hawkey C J. Non‐steroidal anti‐inflammatory drugs and peptic ulcers. BMJ 1990; 300: 278–84
- Myerson R M. NSAID‐associated gastroduodenal damage. J Pharm Med 1992; 2: 277–84
- Battistini B, Botting R, Bakhle Y S. COX‐1 and COX‐2: toward the development of more selective NSAIDs. Drugs News Persp 1994; 7: 501–12
- Ehsanullah R SB, Page M C, Tildesley G, Wood J R. Prevention of gastroduodenal damage induced by non‐steroidal anti‐inflammatory drugs: controlled trial of ranitidine. BMJ 1988; 297: 1017–20
- Verdickt W, Moran C, Hantschel H, Fraga A M, Stead H, Geis G S. A double blind comparison of the gastroduodenal safety and efficacy of diclofenac and a fixed dose combination of diclofenac and misoprostol in the treatment of rheumatoid arthritis. Scand J Rheumatol 1992; 21: 85–91
- Graham D Y, Agrawal N M, Roth S H. Prevention of NSAID‐induced gastric ulcer with misoprostol: multicentre, double‐blind, placebo‐controlled trial. Lancet 1988; 2: 1277–80
- McCarthy D M. NSAID‐induced gastrointestinal damage. J Clin Gastroenterol 1990; 12(Suppl 2)S13–20
- Eriksson S, Långström G, Rikner L, Carlsson R, Naesdal J. Omeprazole and H2‐receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta‐analysis. Eur J Gastroenterol Hepatol 1995; 7: 467–75
- Walan A, Bader J ‐P, Classen M, Lamers C BHW, Piper D W, Rutgersson K, et al. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med 1989; 320: 69–75
- Lauritsen K, Rutgersson K, Bolling E, Brunner G, Eriksson S, Frison L, et al. Omeprazole 20 or 40 mg daily for healing of duodenal ulcer? A double‐blind comparative study. Eur J Gastroenterol Hepatol 1992; 4: 995–1000
- Daneshmend T K, Stein A G, Bhaskar N K, Hawkey C J. Abolition by omeprazole of aspirin induced gastric mucosal injury in man. Gut 1990; 31: 514–7
- Scheiman J M, Behler E M, Loeffler K M, Elta G H. Omeprazole ameliorates aspirin‐induced gastroduodenal injury. Dig Dis Sci 1994; 39: 97–103
- Oddson E, Gudjonsson H, Thjodleifsson B. Comparison between ranitidine and omeprazole for protection against gastroduodenal damage caused by naproxen. Scand J Gastroenterol 1992; 27: 1045–8
- French P C, Darekar B S, Mills J G, Wood J R. Ranitidine in the prevention of non‐steroidal anti‐inflammatory drug‐associated gastric and duodenal ulceration in arthritic patients. Eur J Gastroenterol Hepatol 1994; 6: 1141–7
- Lanza F L, Graham D Y, Davis R E, Rack M F. Endoscopic comparison of cimetidine and sucralfate for prevention of naproxen‐induced acute gastroduodenal injury. Dig Dis Sci 1990; 35: 1494–9
- Ivey K J, Paone D B, Krause W J. Acute effect of systemic aspirin on gastric mucosa in man. Dig Dis Sci 1980; 25: 97–9
- Graham D Y, Smith J L, Dobbs S M. Gastric adaptation occurs with aspirin administration in man. Dig Dis Sci 1983; 28: 1–6